March 2, 2021 Experience Roku $1 billion at-the-market offering The at-the-market SEC-registered offering included shares of Class A common stock
March 1, 2021 Experience I-Mab $177 million follow-on secondary offering of ADSs We advised the underwriters on the equity offering
February 19, 2021 Experience InnoCare Pharma HK$3.04 billion share placement We advised InnoCare Pharma in the placement of new shares
February 17, 2021 Experience Akeso HK$1.19 billion share placement We advised the placing agent in the placement of new shares
February 17, 2021 Experience Youdao $238 million equity follow-on offering We advised Youdao on its offering of ADSs
February 2, 2021 Experience Ocumension Therapeutics HK$793.8 million top-up placement of shares We advised the placing agent in connection with the equity offering
February 2, 2021 Experience Venus Medtech HK$1.4 billion placing of new H shares We advised Venus Medtech (Hangzhou) on its placement of new shares
February 1, 2021 Experience CureVac $450 million public offering We advised CureVac on the equity offering
January 26, 2021 Experience Silvergate Capital $287.5 million follow-on offering We advised the underwriters in connection with the equity offering
January 25, 2021 Experience Innovent Biologics HK$4.73 billion placement of shares We advised the joint placing agents in connection with the equity offering